What is Celiac Disease?
Celiac disease is a chronic, genetic inflammatory autoimmune disorder that is triggered by the ingestion of gluten containing foods such as wheat, barley, and rye. Celiac disease affects people of any age but is commonly diagnosed either in early childhood or in the 40’s. The estimated prevalence of people with Celiac disease is roughly 1% in the United States.
About the Study Medication
Currently, management of this disease includes life-long strict adherence to a gluten free diet which is difficult to do in the real world as gluten may be hidden in food items and cross contamination. No therapeutics are currently available for the treatment of persistent symptoms in patients with celiac disease who are on a gluten free diet.
The Northwest Clinical Research Center is participating in a new clinical trial that consists of the use of novel investigational medication to add to the gluten free diet. This medication is thought to prevent the opening of intestinal tight junctions triggered by gluten. We are seeking volunteers with diagnosed Celiac disease to participate in this clinical trial evaluating if the study medication reduces symptoms of Celiac disease.
No Cost Study
There is no cost to participate in this study. We are looking for volunteers 18 years and older who already have been medically diagnosed with Celiac disease and have symptoms of Celiac disease despite trying a gluten free diet. The study participant who is eligible will receive the following:
- Medical Evaluation.
- Investigational Medication.
- Study Related Medical Care.
- Compensation may be available.
- Complimentary transportation or a travel stipend.